Lafrenière RG*, Cader MZ*, Poulin JF, Andres-Enguix I, Simoneau M, Gupta N, Boisvert K, Lafrenière F, McLaughlan S, Dubé MP, Marcinkiewicz MM,Ramagopalan S, Ansorge O, Brais1 B, Sequeiros J, Pereira-Monteiro JM, Griffiths LR, Tucker SJ, Ebers G & Rouleau GA. (2010) A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med  Oct; 16(10): 1157-60. Sept 26 epub. *Joint first authors

Achilli F, Bros-Facer V, Williams HP, Banks GT, Alqatari M, Chia R, Tucci V, Groves M, Nickols CD, Seburn KL, Kendall R, Cader MZ, Talbot K, van Minnen J, Burgess RW, Brandner S, Martin JE, Koltzenburg M, Greensmith L, Nolan PM, Fisher EM. (2009) An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy. Dis Model Mech Jul-Aug; 2(7-8): 359-73. May 26.

Cader MZ, Ren J, James PA, Bird LE, Talbot K, Stammers DK. (2007) Crystal structure of human wildtype and S581L-mutant glycyl-tRNA synthetase, an enzyme underlying distal spinal muscular atrophy. FEBS Lett Jun 26; 581(16): 2959-64.

Ramagopalan SV, Ramscar NE, Cader MZ. (2007) Molecular mechanisms of migraine? J Neurol Dec; 254(12): 1629-35. Epub 2007 Nov 7.

James PA, Cader MZ, Muntoni F, Childs A, Crow YJ, Talbot K. (2006) Severe childhood SMA and axonal CMT due to anti-codon binding domain mutations in the GARS gene. Neurology Nov 14; 67(9): 1710-12.

Lincoln MR, Montpetit A, Cader MZ, Saarela J, Dyment DA, Tiislar M, Ferretti V, Tienari PJ, Sadovnick AD, Peltonen L, Ebers GC, Hudson TJ. (2005) A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet Oct; 37(10): 1108-12.